Baxter International is a US company operating worldwide in the pharmaceutical and medical technology sectors. The company produces drugs for anesthesiology and intensive care medicine, vaccines and medical devices.
According to Baxter's latest financial reports the company's current earnings are โฌ12.85 Billion. a decrease over its 2023 earnings that were of โฌ0.11 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.
Year | Earnings | Change |
---|---|---|
2024 | -โฌ0.52 Billion | -545.86% |
2023 | โฌ0.11 B | -105.3% |
2022 | -โฌ2.2 Billion | -269.8% |
2021 | โฌ1.29 B | 14.32% |
2020 | โฌ1.13 B | 33.2% |
2019 | โฌ0.84 B | -41.53% |
2018 | โฌ1.45 B | 36.32% |
2017 | โฌ1.06 B | -75.43% |
2016 | โฌ4.33 B | 1057.48% |
2015 | โฌ0.37 B | -79.17% |
2014 | โฌ1.79 B | -18.81% |
2013 | โฌ2.21 B | -12.39% |
2012 | โฌ2.52 B | 2.85% |
2011 | โฌ2.45 B | 48.62% |
2010 | โฌ1.65 B | -30.87% |
2009 | โฌ2.39 B | 11.05% |
2008 | โฌ2.15 B | 16.46% |
2007 | โฌ1.85 B | 21.08% |
2006 | โฌ1.52 B | 20.91% |
2005 | โฌ1.26 B | 233.49% |
2004 | โฌ0.37 B | -62.22% |
2003 | โฌ1.00 B | -18.08% |
2002 | โฌ1.22 B | 45.12% |
2001 | โฌ0.84 B | 1.9% |
2000 | โฌ0.82 B | -9.99% |
1999 | โฌ0.92 B | 99.43% |
1998 | โฌ0.46 B | 0.76% |
1997 | โฌ0.45 B | -34.05% |
1996 | โฌ0.69 B | 51.34% |
1995 | โฌ0.45 B | -34.58% |
1994 | โฌ0.70 B | -342.73% |
1993 | -โฌ0.29 Billion | -142.36% |
1992 | โฌ0.68 B | -3.23% |
1991 | โฌ0.70 B | 666.67% |
1990 | โฌ91.93 M | -83.52% |
1989 | โฌ0.55 B | -14.5% |
1988 | โฌ0.65 B | 7.66% |
1987 | โฌ0.60 B | 26.74% |
1986 | โฌ0.47 B | 115.3% |
1985 | โฌ0.22 B | 10.84% |
1984 | โฌ0.20 B |